Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by Sandblaster1980on Sep 29, 2020 7:46pm
244 Views
Post# 31639639

RE:RE:RE:RE:RE:RE:RE:RE:Approvals

RE:RE:RE:RE:RE:RE:RE:RE:Approvals
creesil wrote:

Couple of factors here:

1. Abbott have ramped up already since they have FDA clearance. Therefore, they can make a decent quantity available immediately to ease some political pressure. 

2. Sona have not ramped up yet because they need a green light first (FDA or HC) if they are being managed prudently. No doubt they're manufacturing kits but not to scale yet.

3. Most of Abbott's supply is spoken for in the US. The US government bought this so they come first always.

4. Canada will purchase kits from multiple sources. Abbott is one source and convenient right now for the reasons above. I believe this was confirmed earlier today.

5. Demand will be huge here. We're on the path to rapid tests being used as the main screening tool to keep the economy open, to keep planes full, to keep work places open with fewer disruptions. The full shut down will be a final resort now. Economies need to stay open from now on.

6. Don't be so focused on one test over another. It's not a concern right now. Personally, I think Sona has a very user friendly and slick test. I don't like the Abbott fold over test very much and I think there are too many steps.
 



Nice summary creesil.
Bullboard Posts